{"id":138460,"date":"2025-11-17T19:10:07","date_gmt":"2025-11-17T19:10:07","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/138460\/"},"modified":"2025-11-17T19:10:07","modified_gmt":"2025-11-17T19:10:07","slug":"a-case-report-of-pancreatic-tuberculosis-arterial-infusion-of-isoniazid-as-an-adjunct-to-oral-antituberculosis-medications-has-demonstrated-promising-therapeutic-efficacy-bmc-infectious-diseases","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/138460\/","title":{"rendered":"A case report of pancreatic tuberculosis: arterial infusion of isoniazid as an adjunct to oral antituberculosis medications has demonstrated promising therapeutic efficacy | BMC Infectious Diseases"},"content":{"rendered":"<p>Currently, the treatment regimen for pancreatic tuberculosis, like that for abdominal tuberculosis, generally follows the protocols used for pulmonary TB [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 3\" title=\"Jullien S, Jain S, Ryan H, Ahuja V. Six-month therapy for abdominal tuberculosis. Cochrane Database Syst Rev. 2016;11(11):CD012163.\" href=\"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11914-2#ref-CR3\" id=\"ref-link-section-d7344087e649\" rel=\"nofollow noopener\" target=\"_blank\">3<\/a>]. Standard first-line ATT administered over 6\u201312 months demonstrates favorable outcomes in various studies. This case report marks the first documented use of RAI of isoniazid combined with oral antituberculosis medications for treating pancreatic tuberculosis.<\/p>\n<p>RAI has not been utilized in previously reported cases. RAI therapy emerged in the 1960s, initially targeting severe acute pancreatitis and inoperable advanced tumors. The cytotoxic effects of the drug on tumor cells are concentration-dependent. The central principle of treatment is to achieve a localized high concentration of the drug through arterial infusion around the lesion, thereby maximizing therapeutic efficacy while minimizing collateral damage to unaffected organs.<\/p>\n<p>The advantages of RAI are as follows [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 4\" title=\"Endo A, Shiraishi A, Fushimi K, Murata K, Otomo Y. Impact of continuous regional arterial infusion in the treatment of acute necrotizing pancreatitis: analysis of a National administrative database. J Gastroenterol. 2018;53(9):1098\u2013106.\" href=\"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11914-2#ref-CR4\" id=\"ref-link-section-d7344087e660\" rel=\"nofollow noopener\" target=\"_blank\">4<\/a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 5\" title=\"Huang C, Cheng CS, Shen Y, Chen H, Lin J, Hua Y, et al. Digital Subtraction angiography-guided pancreatic arterial infusion of GEMOX chemotherapy in advanced pancreatic adenocarcinoma: a phase II, open-label, randomized controlled trial comparing with intravenous chemotherapy. BMC Cancer. 2024;24(1):941.\" href=\"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11914-2#ref-CR5\" id=\"ref-link-section-d7344087e663\" rel=\"nofollow noopener\" target=\"_blank\">5<\/a>]:<\/p>\n<p>                  1.<\/p>\n<p>In intravenous administration, pancreatic blood flow constitutes only 0.8% of the total cardiac output, making it challenging for the pancreas to achieve an optimal therapeutic drug concentration after systemic administration.<\/p>\n<p>                  2.<\/p>\n<p>RAI involves the direct injection of drugs into the nutrient arteries supplying the diseased area of the pancreas. This method increases drug concentration in the region by 5 to 10 times compared to systemic intravenous administration, making RAI a potent approach for enhancing the treatment of severe acute pancreatitis and Pancreatic cancer from a pharmacokinetic perspective.<\/p>\n<p>                  3.<\/p>\n<p>RAI selectively or super-selectively delivers drugs directly into the nutrient arteries of the diseased pancreatic area, thereby circumventing the hepatic first-pass effect and allowing for a rapid and sustained increase in local drug concentration. Additionally, following arterial administration, the drug enters the liver through the portal vein, where it undergoes metabolism, potentially reducing systemic adverse effects.<\/p>\n<p>Tuberculous granulomas, the common form of tuberculous lesions, are typically composed of centrally located activated macrophages harboring tuberculosis bacteria, surrounded by peripheral lymphocytes and fibroblasts. After enhanced MRI analysis, the peripheral enhancement seen in these lesions highlights the distinct arterial blood supply to tuberculous granulomas, providing a theoretical basis for the use of RAI. Isoniazid is the first-line drug for the treatment of tuberculosis and is effective in managing both active tuberculosis and latent infections [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 6\" title=\"Erwin ER, Addison AP, John SF, Olaleye OA, Rosell RC. Pharmacokinetics of isoniazid: the good, the bad, and the alternatives. Tuberculosis (Edinb). 2019;116S:S66\u201370.\" href=\"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11914-2#ref-CR6\" id=\"ref-link-section-d7344087e707\" rel=\"nofollow noopener\" target=\"_blank\">6<\/a>]. It is often used as a monotherapy or in combination with other agents. Isoniazid exhibits selective antibacterial activity against Mycobacterium species, likely due to its ability to inhibit the synthesis of mycolic acid, which is essential for the formation of the bacterial cell wall.<\/p>\n<p>We administered a dose of 300\u00a0mg for arterial infusion in the patient, which corresponds to a single oral dose used in pharmacological treatment. Additionally, there is no cross-resistance between isoniazid and other anti-tuberculosis drugs, facilitating subsequent oral drug therapy for the patient. High-concentration isoniazid infusion therapy at the local site caused transient impairment of liver function in the patient. The AST and ALT levels declined below admission levels within one week.<\/p>\n<p>In comparison with previous case reports and literature reviews, the 13-month total treatment duration in our case did not demonstrate significant temporal differences from conventional regimens. However, the rapid alleviation of the patient\u2019s epigastric distension and pain through regional arterial infusion (RAI) therapy provided substantial clinical benefits during the initial treatment phase. This early symptom resolution markedly improved the patient\u2019s quality of life and psychological distress at the critical onset period. While these observations are inherently limited by the single-case nature of this report, all therapeutic decisions were strictly guided by immediate clinical necessities, and the outcomes reflect objective treatment responses. Additional case series will be required to establish the long-term outcomes and safety of this therapeutic strategy.<\/p>\n<p>Recent years have seen a gradual increase in case reports of pancreatic tuberculosis, yet comprehensive epidemiological data on its exact incidence remain incomplete. The occurrence of solitary pancreatic tuberculosis, as presented in this case, is an even rarer event. This rarity could be due to the antimycobacterial properties of pancreatic lipase and deoxyribonuclease [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 7\" title=\"Knowles KF, Saltman D, Robson HG, Lalonde R. Tuberculous pancreatitis. Tubercle. 1990;71(1):65\u20138.\" href=\"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11914-2#ref-CR7\" id=\"ref-link-section-d7344087e722\" rel=\"nofollow noopener\" target=\"_blank\">7<\/a>]. Destructive lesions typically develop only after the inoculation of a significant quantity of Mycobacterium tuberculosis into the pancreatic parenchyma within a short period. The mechanisms by which Mycobacterium tuberculosis invades the pancreas are not well understood. Potential infection pathways include hematogenous and lymphatic dissemination from latent or secondary tuberculosis infections. Another possible route is from contiguous organ involvement, notably in cases of intestinal tuberculosis where TB originates from TB organisms within the liver and spreads via the biliary tract [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 8\" title=\"Eraksoy H. Gastrointestinal and abdominal tuberculosis. Gastroenterol Clin North Am. 2021;50(2):341\u201360.\" href=\"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11914-2#ref-CR8\" id=\"ref-link-section-d7344087e725\" rel=\"nofollow noopener\" target=\"_blank\">8<\/a>].<\/p>\n<p>Clinical symptoms in patients with pancreatic tuberculosis are generally consistent, often beginning with acute or chronic abdominal pain and discomfort, which can lead to complications such as gastrointestinal bleeding [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 9\" title=\"Chen CH, Yang CC, Yeh YH, Yang JC, Chou DA. Pancreatic tuberculosis with obstructive jaundice\u2013a case report. Am J Gastroenterol. 1999;94(9):2534\u20136.\" href=\"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11914-2#ref-CR9\" id=\"ref-link-section-d7344087e731\" rel=\"nofollow noopener\" target=\"_blank\">9<\/a>] or acute\/chronic pancreatitis [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 10\" title=\"De Backer AI, Mortel\u00e9 KJ, Bomans P, De Keulenaer BL, Vanschoubroeck IJ, Kockx MM. Tuberculosis of the pancreas: MRI features. AJR Am J Roentgenol. 2005;184(1):50\u20134.\" href=\"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11914-2#ref-CR10\" id=\"ref-link-section-d7344087e734\" rel=\"nofollow noopener\" target=\"_blank\">10<\/a>]. An analysis of 166 cases of pancreatic tuberculosis showed a higher diagnosis rate among Asians [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 11\" title=\"Panic N, Maetzel H, Bulajic M, Radovanovic M, L\u00f6hr JM. Pancreatic tuberculosis: A systematic review of symptoms, diagnosis and treatment. United Eur Gastroenterol J. 2020;8(4):396\u2013402.\" href=\"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11914-2#ref-CR11\" id=\"ref-link-section-d7344087e737\" rel=\"nofollow noopener\" target=\"_blank\">11<\/a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 12\" title=\"Meesiri S. Pancreatic tuberculosis with acquired immunodeficiency syndrome: a case report and systematic review. World J Gastroenterol. 2012;18(7):720\u20136.\" href=\"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11914-2#ref-CR12\" id=\"ref-link-section-d7344087e740\" rel=\"nofollow noopener\" target=\"_blank\">12<\/a>], with an average age of 41.6 \u00b1 13.95 years and a male predominance, aligning with the demographic profile of the patient in this case. Among these patients, 25.3% were co-infected with HIV. Furthermore, the mortality rate among patients with confirmed pancreatic TB was 10.8% during hospitalization, with a follow-up mortality rate of 37.5% observed over a period ranging from 3 weeks to 32 months.<\/p>\n<p>Pancreatic tuberculosis can occur in all anatomical regions of the pancreas, including the head and tail, with the pancreatic head being the most frequently involved site [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 13\" title=\"Kim JB, Lee SS, Kim SH, Byun JH, Park DH, Lee TY, et al. Peripancreatic tuberculous lymphadenopathy masquerading as pancreatic malignancy: a single-center experience. J Gastroenterol Hepatol. 2014;29(2):409\u201316.\" href=\"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11914-2#ref-CR13\" id=\"ref-link-section-d7344087e746\" rel=\"nofollow noopener\" target=\"_blank\">13<\/a>]. The lesions typically manifest as solid masses or cystic formations, often demonstrating radiographic calcifications. These pathological changes may cause compression or obstruction of adjacent vascular structures, including the portal vein, superior mesenteric vein, and hepatic artery [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 14\" title=\"Rana SS, Sharma V, Sampath S, Sharma R, Mittal BR, Bhasin DK. Vascular invasion does not discriminate between pancreatic tuberculosis and pancreatic malignancy: a case series. Ann Gastroenterol. 2014;27(4):395\u20138.\" href=\"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11914-2#ref-CR14\" id=\"ref-link-section-d7344087e749\" rel=\"nofollow noopener\" target=\"_blank\">14<\/a>]. During the initial imaging diagnosis, differential diagnosis between pancreatic tuberculosis and pancreatic cystic neoplasms must be carefully considered [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 15\" title=\"Hu F, Hu Y, Wang D, Ma X, Yue Y, Tang W, et al. Cystic neoplasms of the pancreas: differential diagnosis and radiology correlation. Front Oncol. 2022;12:860740.\" href=\"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11914-2#ref-CR15\" id=\"ref-link-section-d7344087e752\" rel=\"nofollow noopener\" target=\"_blank\">15<\/a>]. The laboratory indicators of pancreatic tuberculosis exhibit limited specificity. As an infectious pathology, pancreatic tuberculosis typically presents with an elevated erythrocyte sedimentation rate (ESR) and variations in blood parameters, which are potential markers for initially differentiating between pancreatic lesions and neoplastic processes. Pancreatic tuberculosis may also show elevated levels of tumor markers such as CA125 and CA199 [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 16\" title=\"Sun PJ, Lin Y, Cui XJ. Isolated pancreatic tuberculosis with elevated CA 19\u2009\u2013\u20099 levels masquerading as a malignancy: A rare case report and literature review. Med (Baltim). 2018;97(52):e13858.\" href=\"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11914-2#ref-CR16\" id=\"ref-link-section-d7344087e755\" rel=\"nofollow noopener\" target=\"_blank\">16<\/a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 17\" title=\"Gu Y, Xiao M, Wan Z, Li Q. Isolated pancreatic tuberculosis masquerading as malignancy in an immunocompetent host: a case report and review of the literature. J Int Med Res. 2023;51(8):3000605231189134.\" href=\"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11914-2#ref-CR17\" id=\"ref-link-section-d7344087e758\" rel=\"nofollow noopener\" target=\"_blank\">17<\/a>], as well as increased AFP levels, which could lead to a misdiagnosis as pancreatic cancer. The rise in CA199 levels has been linked to potential associations with pancreatic head masses and gallbladder obstruction caused by enlarged lymph nodes.<\/p>\n<p>EUS-FNA has become an essential diagnostic tool for evaluating pancreatic and peripancreatic lesions, as well as for investigating abdominal masses and enlarged lymph nodes. When conventional acid-fast bacilli tests are negative despite clinical suspicion of tuberculosis, EUS-FNA should be considered as a diagnostic adjunct [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 18\" title=\"Sharma V, Rana SS, Kumar A, Bhasin DK. Pancreatic tuberculosis. J Gastroenterol Hepatol. 2016;31(2):310\u20138.\" href=\"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11914-2#ref-CR18\" id=\"ref-link-section-d7344087e765\" rel=\"nofollow noopener\" target=\"_blank\">18<\/a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 19\" title=\"Puri R, Mangla R, Eloubeidi M, Vilmann P, Thandassery R, Sud R. Diagnostic yield of EUS-guided FNA and cytology in suspected tubercular intra-abdominal lymphadenopathy. Gastrointest Endosc. 2012;75(5):1005\u201310.\" href=\"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11914-2#ref-CR19\" id=\"ref-link-section-d7344087e768\" rel=\"nofollow noopener\" target=\"_blank\">19<\/a>].<\/p>\n<p>In summary, isolated pancreatic tuberculosis represents a rare clinical entity. We have presented a comprehensive documentation of the diagnostic and therapeutic process in this case. The RAI therapy provided prompt resolution of the patient\u2019s epigastric distension and pain symptoms, while subsequent combination with ATT demonstrated favorable therapeutic outcomes.<\/p>\n","protected":false},"excerpt":{"rendered":"Currently, the treatment regimen for pancreatic tuberculosis, like that for abdominal tuberculosis, generally follows the protocols used for&hellip;\n","protected":false},"author":2,"featured_media":138461,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[85941,47427,163,85,4746,3861,46,18494,10738,18493,85942,18495,20646],"class_list":{"0":"post-138460","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health","8":"tag-angiography","9":"tag-case-report","10":"tag-health","11":"tag-il","12":"tag-infectious-diseases","13":"tag-internal-medicine","14":"tag-israel","15":"tag-medical-microbiology","16":"tag-pancreas","17":"tag-parasitology","18":"tag-regional-arterial-infusion","19":"tag-tropical-medicine","20":"tag-tuberculosis"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/138460","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=138460"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/138460\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/138461"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=138460"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=138460"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=138460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}